Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 46.2% in First Quarter of 2022

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 150.9 million yuan in the first quarter of 2022, down 46.2% year-on-year.

Meanwhile, the company posted 366.3 million yuan in revenue, down 38.5% year-on-year.

At the end of the reporting period, it had 9.9 billion yuan in total assets and 387 million yuan in total liabilities, with a liability-to-asset ratio of 3.9%.